GIOSTAR: The Shining Star of Modern Healthcare Industry & BioTech

The human body can have losses in the functioning of organs because of tissue losses caused by diseases or injuries. This predicament enforces demands for the development of treatments that can regenerate tissues, and thereby, decrease reliance on organ transplantations. Regenerative medicine is a rapidly evolving medical field that deploys doctrines of engineering and life…

Read More

Giostar has agreed to commercialize and promote dcgi (Indian FDA) approved stem cell therapies for critical lab ischemia and osteoarthritis

GIOSTAR has agreed to commercialize and promote DCGI (Indian FDA) approved stem cell therapies for Critical Lab Ischemia and Osteoarthritis to suffering masses in India and abroad that is developed by STEMPEUTICS Research Private Limited for Cipla and Kemwell Biopharma. GIOSTAR, a pioneering global stem cell research organization, via STEMPEUTICS, an Indian biotechnology company which…

Read More

Honourable Speaker DR Anand Srivastava at 1ST INTERNATIONAL CONFERENCE ON MEDICINE AND RESEARCH (ICMR-21)

ICMR-21

Topic : Role of Stem Cell in Covid-19 Dr. Srivastava is a Chairman and Cofounder of the California-based Global Institute of Stem Cell Therapy and Research (GIOSTAR) headquartered in San Diego, California (USA). Several governments and organizations – including the United States, India, China, Turkey, Kuwait, Thailand, Philippines, Bahamas, Saudi Arabia and many others seek…

Read More

Health Talk on Metabolic Diseases Can Be Cured by Stem Cell Therapy at USTM, Guwahati on Dec 18, 2021, by DR. Anand Srivastava Chairman GIOSTAR- USA.

Metabolic

GUWAHATI, Dec 18 : “Stem cell based therapy can aid those suffering from degenerative or genetic diseases such as Parkinson’s, Alzheimer’s, Autism, Diabetes, Heart Disease, Stroke, Spinal Cord Injuries, Paralysis, Blood Related Diseases, Cancer and Burns.” This has been stated by Dr Anand S Shrivastava, Director & Co founder, Global Institute of Stem Cell Therapy…

Read More